Abstract
The decrease of bone mineral density, osteopenia, and changes in bone tissue structure in postmenopausal osteoporosis (PMO) are related to the disturbance of the body's microbiota, but the specific mechanism is still unclear. Cistanche deserticola Y. C. Ma. (Orobanchaceae, CD) is a medicinal and dietary herb widely used in China, and studies have been conducted to prove its effectiveness in the treatment of postmenopausal osteoporosis. This study aims to investigate the potential mechanism of cell-broken decoction pieces of Cistanche deserticola (CDC) in regulating gut microbiota and gut microbial metabolites to improve postmenopausal osteoporosis. The results show that CDC improved gut microbiota disorders, and promoted the production of beneficial bacteria of Firmicutes, Roseburia, and Oscillibacter that mainly produce SCFAs, and increased intestinal barrier function, thus protecting OVX mice from bone loss, which provides a reference for the clinical application of CDC in the prevention and treatment of PMO.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
